Inhibition of Xenograft Tumor Growth by Gold Nanoparticle-DNA Oligonucleotide Conjugates-Assisted Delivery of BAX mRNA

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yeom, Ji Hyun ^a   Ryou, Sang Mi ^a   Won, Miae ^b   Park, Mira ^b   Bae, Jeehyeon ^a   Lee, Kangseok ^a  

^a Chung Ang University   (South Korea)

^b CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GOLD NANOPARTICLE DNA OLIGONUCLEOTIDE CONJUGATE; NANOCONJUGATE; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; DNA; DRUG DELIVERY SYSTEMS; FEMALE; GENETIC THERAPY; GOLD; HETEROGRAFTS; HUMANS; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGONUCLEOTIDES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 84884485314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075369     Document Type: Article

References (31)

1. Kreiter S, Diken M, Selmi A, Türeci Ö, Sahin U, (2011) Tumor vaccination using messenger RNA: prospects of a future therapy. Curr Opin Immunol 23: 399-406. doi:10.1016/j.coi.2011.03.007. PubMed: 21497074.
2. Yamamoto A, Kormann M, Rosenecker J, Rudolph C, (2009) Current prospects for mRNA gene delivery. Eur J Pharm Biopharm 71: 484-489. doi:10.1016/j.ejpb.2008.09.016. PubMed: 18948192.
3. Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, et al. (2011) mRNA as gene therapeutic: How to control protein expression. J Control Release 150: 238-247. doi:10.1016/j.jconrel.2010.10.020. PubMed: 20970469.
4. Malone RW, Felgner PL, Verma IM, (1989) Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci U S A 86: 6077-6081. doi:10.1073/pnas.86.16.6077. PubMed: 2762315.
5. Bettinger T, Carlisle RC, Read ML, Ogris M, Seymour LW, (2001) Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res 29: 3882-3891. doi:10.1093/nar/29.18.3882. PubMed: 11557821.
6. Fisher KJ, Wilson JM, (1997) The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem J 321: 49-58. PubMed: 9003400.
7. Strobel I, Berchtold S, Götze A, Schulze U, Schuler G, et al. (2000) Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Ther 7: 2028-2035. doi:10.1038/sj.gt.3301326. PubMed: 11175315.
8. Lu D, Benjamin R, Kim M, Conry RM, Curiel DT, (1994) Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther 1: 245-252. PubMed: 7627814.
9. Karikó K, Keller JM, Harris VA, Langer DJ, Welsh FA, (2001) In vivo protein expression from mRNA delivered into adult rat brain. J Neurosci Methods 105: 77-86. doi:10.1016/S0165-0270(00)00355-1. PubMed: 11166368.
10. Zohra FT, Chowdhury EH, Akaike T, (2009) High performance mRNA transfection through carbonate apatite-cationic liposome conjugates. Biomaterials 30: 4006-4013. doi:10.1016/j.biomaterials.2009.02.050. PubMed: 19410288.
11. Su X, Fricke J, Kavanagh DG, Irvine DJ, (2011) In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Mol Pharm 8: 774-787. doi:10.1021/mp100390w. PubMed: 21417235.
12. Kormann MS, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, et al. (2011) Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 29: 154-157. doi:10.1038/nbt.1733. PubMed: 21217696.
13. Hofland HE, Nagy D, Liu JJ, Spratt K, Lee YL, et al. (1997) In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res 14: 742-749. doi:10.1023/A:1012146305040. PubMed: 9210191.
14. Bragonzi A, Boletta A, Biffi A, Muggia A, Sersale G, et al. (1999) Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther 6: 1995-2004. doi:10.1038/sj.gt.3301039. PubMed: 10637451.
15. Filion MC, Phillips NC, (1997) Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta 1329: 345-356. doi:10.1016/S0005-2736(97)00126-0. PubMed: 9371426.
16. Filion MC, Phillips NC, (1998) Major limitations in the use of cationic liposomes for DNA delivery. Int J Pharm 162: 159-170. doi:10.1016/S0378-5173(97)00423-7.
17. Tros de Ilarduya C, Arangoa MA, Düzgüneş N, (2003) Transferrin-lipoplexes with protamine-condensed DNA for serum-resistant gene delivery. Methods Enzymol 373: 342-356. doi:10.1016/S0076-6879(03)73022-5. PubMed: 14714414.
18. Kim JH, Jang HH, Ryou SM, Kim S, Bae J, et al. (2010) A functionalized gold nanoparticles-assisted universal carrier for antisense DNA. Chem Commun (Camb) 46: 4151-4153. doi:10.1039/c0cc00103a.
19. Ryou SM, Kim S, Jang HH, Kim JH, Yeom JH, et al. (2010) Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier. Biochem Biophys Res Commun 398: 542-546. doi:10.1016/j.bbrc.2010.06.115. PubMed: 20599759.
20. Kim JH, Yeom JH, Ko JJ, Han MS, Lee K, et al. (2011) Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. J Biotechnol 155: 287-292. doi:10.1016/j.jbiotec.2011.07.014. PubMed: 21807040.
21. Ryou SM, Kim JM, Yeom JH, Hyun S, Kim S, et al. (2011) Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells. Biochem Biophys Res Commun 416: 178-183. doi:10.1016/j.bbrc.2011.11.020. PubMed: 22093830.
22. Ghosh P, Han G, De M, Kim CK, Rotello VM, (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60: 1307-1315. doi:10.1016/j.addr.2008.03.016. PubMed: 18555555.
23. Kim JM, Shin E, Ryou SM, Yeom JH, Lee K, (2013) Gene delivery platforms. Biotechnol Bioprocess Eng, 18: 637-647. doi:10.1007/s12257-012-0546-8.
24. Zhang X, Servos MR, Liu J, (2012) Instantaneous and quantitative functionalization of gold nanoparticles with thiolated DNA using a pH-assisted and surfactant-free route. J Am Chem Soc 134: 7266-7269. doi:10.1021/ja3014055. PubMed: 22506486.
25. Pelletier J, Sonenberg N, (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334: 320-325. doi:10.1038/334320a0. PubMed: 2839775.
26. Renault TT, Manon S, (2011) Bax: Addressed to kill. Biochimie 93: 1379-1391. doi:10.1016/j.biochi.2011.05.013. PubMed: 21641962.
27. Kuhn AN, Beiβert T, Simon P, Vallazza B, Buck J, et al. (2012) mRNA as a versatile tool for exogenous protein expression. Curr Gene Ther 12: 347-361. doi:10.2174/156652312802762536. PubMed: 22827224.
28. Schott JW, Galla M, Godinho T, Baum C, Schambach A, (2011) Viral and non-viral approaches for transient delivery of mRNA and proteins. Curr Gene Ther 11: 382-398. doi:10.2174/156652311797415872. PubMed: 21787295.
29. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, et al. (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312: 1027-1030. doi:10.1126/science.1125559. PubMed: 16709779.
30. Park S, Hamad-Schifferli K, (2010) Enhancement of in vitro translation by gold nanoparticle-DNA conjugates. ACS Nano 4: 2555-2560. doi:10.1021/nn100362m. PubMed: 20384314.
31. Kim YJ, Ryou SM, Kim S, Yeom JH, Han MS, et al. (2012) Enhanced protein-mediated binding between oligonucleotide-gold nanoparticle composites and cell surfaces: co-transport of proteins and composites. J Mater Chem 22: 25036-25041. doi:10.1039/c2jm34047j.